These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10415632)

  • 21. Prescribing for thrombophilia--are we going to repeat mistakes of the past?
    Jivraj S
    Gynecol Obstet Invest; 2004; 58(4):219; author reply 220. PubMed ID: 15331855
    [No Abstract]   [Full Text] [Related]  

  • 22. Low-molecular-weight heparin versus intravenous immunoglobulin for recurrent abortion associated with antiphospholipid antibody syndrome.
    Dendrinos S; Sakkas E; Makrakis E
    Int J Gynaecol Obstet; 2009 Mar; 104(3):223-5. PubMed ID: 19116178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of pregnant women with recurrent miscarriage associated with phospholipid antibodies. General prognosis is favourable in untreated women.
    Christiansen OB
    BMJ; 1997 Aug; 315(7104):372; author reply 373. PubMed ID: 9270477
    [No Abstract]   [Full Text] [Related]  

  • 24. Antiphospholipid antibody syndrome.
    Kutteh WH; Hinote CD
    Obstet Gynecol Clin North Am; 2014 Mar; 41(1):113-32. PubMed ID: 24491987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin.
    Noble LS; Kutteh WH; Lashey N; Franklin RD; Herrada J
    Fertil Steril; 2005 Mar; 83(3):684-90. PubMed ID: 15749498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Occasional antiphospholipid antibody positive patients with recurrent pregnancy loss also merit aspirin therapy: a retrospective cohort-control study.
    Sugiura-Ogasawara M; Ozaki Y; Nakanishi T; Sato T; Suzumori N; Kumagai K
    Am J Reprod Immunol; 2008 Mar; 59(3):235-41. PubMed ID: 18275516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pregnancy and antiphospholipid antibodies].
    Le Guern V; Goffinet F
    Presse Med; 2008 Nov; 37(11):1666-75. PubMed ID: 18829248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enoxaparin versus unfractionated heparin in the management of recurrent abortion secondary to antiphospholipid syndrome.
    Fouda UM; Sayed AM; Abdou AM; Ramadan DI; Fouda IM; Zaki MM
    Int J Gynaecol Obstet; 2011 Mar; 112(3):211-5. PubMed ID: 21251653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiphospholipid antibody syndrome: implications for nursing practice.
    Brenner ZR; Myer SA
    Heart Lung; 2000; 29(5):331-9. PubMed ID: 10986527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the HepASA trial.
    Carp HJ
    J Rheumatol; 2010 Jan; 37(1):202; author reply 203. PubMed ID: 20040643
    [No Abstract]   [Full Text] [Related]  

  • 31. [Antiphospholipid syndrome and pregnancy].
    Gadó K; Domján G
    Orv Hetil; 2012 Aug; 153(31):1207-18. PubMed ID: 22846489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies.
    Triolo G; Ferrante A; Ciccia F; Accardo-Palumbo A; Perino A; Castelli A; Giarratano A; Licata G
    Arthritis Rheum; 2003 Mar; 48(3):728-31. PubMed ID: 12632426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heparin or aspirin or both in the treatment of recurrent abortions in women with antiphospholipid antibody (syndrome).
    Hoppe B; Burmester GR; Dörner T
    Curr Opin Rheumatol; 2011 May; 23(3):299-304. PubMed ID: 21346577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of pregnant women with recurrent miscarriage associated with phospholipid antibodies. During pregnancy, heparin should be stopped during labour and then restarted soon after delivery.
    Piette JC; Huong DL; Wechsler B
    BMJ; 1997 Aug; 315(7104):372-3; author reply 373. PubMed ID: 9270479
    [No Abstract]   [Full Text] [Related]  

  • 35. A randomized, double-blind, placebo-controlled trial of heparin and aspirin for women with in vitro fertilization implantation failure and antiphospholipid or antinuclear antibodies.
    Stern C; Chamley L; Norris H; Hale L; Baker HW
    Fertil Steril; 2003 Aug; 80(2):376-83. PubMed ID: 12909502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Down-regulation of maternal antiphospholipid antibodies during early pregnancy and pregnancy outcome.
    Kwak JY; Barini R; Gilman-Sachs A; Beaman KD; Beer AE
    Am J Obstet Gynecol; 1994 Jul; 171(1):239-46. PubMed ID: 8030706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiphospholipid syndrome and pregnancy loss.
    Rai R; Regan L
    Hosp Med; 1998 Aug; 59(8):637-9. PubMed ID: 9829058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiphospholipid syndrome in pregnancy.
    Bick RL
    Hematol Oncol Clin North Am; 2008 Feb; 22(1):107-20, vii. PubMed ID: 18207069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heparin plus aspirin as a "single" therapy for recurrent spontaneous abortion associated with both allo- and autoimmunity.
    Cadavid A; Peña B; García G; Botero J; Sánchez F; Ossa J; Beer A
    Am J Reprod Immunol; 1999 Apr; 41(4):271-8. PubMed ID: 10374704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiphospholipid antibodies: a major advance in the management of recurrent abortion.
    Balasch J
    Autoimmun Rev; 2004 Mar; 3(3):228-33. PubMed ID: 15110236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.